For example, the importance of HER2 (also known as EGFER, epidermal growth factor receptor) and the clinical use of trastuzumab (a monoclonal antibody against HER2) to treat GC patients are now widely accepted [5, 6, 7]. The gene discussed is ERBB2; the disease is gastric cancer.